Dallah Healthcare Company (4004.SR) SAU
120.10
-2.4(-1.96%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
120.10
-2.4(-1.96%)
Currency In SAR
| Market Cap | 12.69B |
| Enterprise Value | 16.42B |
| P/E Ratio | 22.68 |
| PEG Ratio | 2.03 |
| Price/Sales Ratio | 2.99 |
| Price/Book Ratio | 2.99 |
| Enterprise/Revenue | 3.9 |
| Enterprise/EBITDA | 20.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.13 |
| Operating Margin | 0.14 |
| Return On Assets | 0.06 |
| Return On Equity | 0.13 |
| Revenue | 4.07B |
| Revenue/Share | 39.97 |
| Gross Profit | 1.42B |
| EBITDA | 783.5M |
| Net Income | 538M |
| Diluted EPS | 5.32 |
| Total Cash | 210.57M |
| Total Cash/Share | 2.07 |
| Total Debt | 3.93B |
| Total Debt/Equity | 0.96 |
| Current Ratio | 1.24 |
| Book Value Per Share | 40.5 |
| 52-Week Change | -4.38 |
| 52-Week High | 157.3 |
| 52-Week Low | 90 |
| Moving Average 50 Days | 119.08 |
| Moving Average 200 Days | 129.97 |
| Average Volume | 156,366 |
| Shares Outstanding | 101.2M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 1.67 |
| Payout Ratio | 0.38 |
| Last Split Factor | 6:5 |
| Last Split Date | September 14, 2020 |